Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Turn Therapeutics Inc. before investing.

In this article, we go over a few key elements for understanding Turn Therapeutics Inc.’s stock price such as:

• Turn Therapeutics Inc.’s current stock price and volume
• Why Turn Therapeutics Inc.’s stock price changed recently
• Upgrades and downgrades for TTRX from analysts
• TTRX’s stock price momentum as measured by its relative strength

About Turn Therapeutics Inc. (TTRX)

Before we jump into Turn Therapeutics Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Want to learn more about Turn Therapeutics Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Turn Therapeutics Inc..

Turn Therapeutics Inc.’s Stock Price as of Market Close

As of February 26, 2026, 1:47 PM, CST, Turn Therapeutics Inc.’s stock price was $3.630.

Turn Therapeutics Inc. is up 4.31% from its previous closing price of $3.480.

During the last market session, Turn Therapeutics Inc.’s stock traded between $3.530 and $4.010. Currently, there are approximately 27.98 million shares outstanding for Turn Therapeutics Inc..

Turn Therapeutics Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Turn Therapeutics Inc. Stock Price History

Turn Therapeutics Inc.’s (TTRX) price is currently down 11.89% so far this month.

During the month of February, Turn Therapeutics Inc.’s stock price has reached a high of $4.300 and a low of $3.200.

Over the last year, Turn Therapeutics Inc. has hit prices as high as $26.500 and as low as $2.570. Year to date, Turn Therapeutics Inc.’s stock is down 7.87%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Turn Therapeutics Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 25, 2026, there were analysts who downgraded Turn Therapeutics Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Turn Therapeutics Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Turn Therapeutics Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Turn Therapeutics Inc. (TTRX) by visiting AAII Stock Evaluator.

Relative Price Strength of Turn Therapeutics Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 25, 2026, Turn Therapeutics Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Turn Therapeutics Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Turn Therapeutics Inc. Stock Price: Bottom Line

As of February 26, 2026, Turn Therapeutics Inc.’s stock price is $3.630, which is up 4.31% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Turn Therapeutics Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.